TY - JOUR
T1 - Engineered Zn2+ switches in the γ-aminobutyric acid (GABA) transporter-1. Differential effects on GABA uptake and currents
AU - MacAulay, Nanna
AU - Bendahan, Annie
AU - Loland, Claus Juul
AU - Zeuthen, Thomas
AU - Kanner, Baruch I.
AU - Gether, Ulrik
PY - 2001/11/2
Y1 - 2001/11/2
N2 - Two high affinity Zn2+ binding sites were engineered in the otherwise Zn2+-insensitive rat γ-aminobutyric acid (GABA) transporter-1 (rGAT-1) based on structural information derived from Zn 2+ binding sites engineered previously in the homologous dopamine transporter. Introduction of a histidine (T349H) at the extracellular end of transmembrane segment (TM) 7 together with a histidine (E370H) or a cysteine (Q374C) at the extracellular end of TM 8 resulted in potent inhibition of [ 3H]GABA uptake by Zn2+ (IC50 = 35 and 44 μM, respectively). Upon expression in Xenopus laevis oocytes it was similarly observed that Zn2+ was a potent inhibitor of the GABA-induced current (IC50 = 21 μM for T349H/E370H and 51 μM for T349H/Q374C), albeit maximum inhibition was only ∼40% in T349H/E370H versus ∼90% in T349H/Q374C. In the wild type, Zn2+ did not affect the Na+-dependent transient currents elicited by voltage jumps and thought to reflect capacitive charge movements associated with Na+ binding. However, in both mutants Zn2+ caused a reduction of the inward transient currents upon jumping to hyperpolarized potentials as reflected in rightward-shifted Q/V relationships. This suggests that Zn 2+ is inhibiting transporter function by stabilizing the outward-facing Na+-bound state. Translocation of lithium by the transporter does not require GABA binding and analysis of this uncoupled Li + conductance revealed a potent inhibition by Zn2+ in T349H/E370H, whereas surprisingly the T349H/Q374C leak was unaffected. This differential effect supports that the leak conductance represents a unique operational mode of the transporter involving conformational changes different from those of the substrate translocation process. Altogether our results support both an evolutionary conserved structural organization of the TM 7/8 domain and a key role of this domain in GABA-dependent and -independent conformational changes of the transporter.
AB - Two high affinity Zn2+ binding sites were engineered in the otherwise Zn2+-insensitive rat γ-aminobutyric acid (GABA) transporter-1 (rGAT-1) based on structural information derived from Zn 2+ binding sites engineered previously in the homologous dopamine transporter. Introduction of a histidine (T349H) at the extracellular end of transmembrane segment (TM) 7 together with a histidine (E370H) or a cysteine (Q374C) at the extracellular end of TM 8 resulted in potent inhibition of [ 3H]GABA uptake by Zn2+ (IC50 = 35 and 44 μM, respectively). Upon expression in Xenopus laevis oocytes it was similarly observed that Zn2+ was a potent inhibitor of the GABA-induced current (IC50 = 21 μM for T349H/E370H and 51 μM for T349H/Q374C), albeit maximum inhibition was only ∼40% in T349H/E370H versus ∼90% in T349H/Q374C. In the wild type, Zn2+ did not affect the Na+-dependent transient currents elicited by voltage jumps and thought to reflect capacitive charge movements associated with Na+ binding. However, in both mutants Zn2+ caused a reduction of the inward transient currents upon jumping to hyperpolarized potentials as reflected in rightward-shifted Q/V relationships. This suggests that Zn 2+ is inhibiting transporter function by stabilizing the outward-facing Na+-bound state. Translocation of lithium by the transporter does not require GABA binding and analysis of this uncoupled Li + conductance revealed a potent inhibition by Zn2+ in T349H/E370H, whereas surprisingly the T349H/Q374C leak was unaffected. This differential effect supports that the leak conductance represents a unique operational mode of the transporter involving conformational changes different from those of the substrate translocation process. Altogether our results support both an evolutionary conserved structural organization of the TM 7/8 domain and a key role of this domain in GABA-dependent and -independent conformational changes of the transporter.
UR - http://www.scopus.com/inward/record.url?scp=0035798631&partnerID=8YFLogxK
U2 - 10.1074/jbc.M105578200
DO - 10.1074/jbc.M105578200
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11527967
AN - SCOPUS:0035798631
SN - 0021-9258
VL - 276
SP - 40476
EP - 40485
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 44
ER -